Thermo Fisher Scientific SYNPO2 Polyclonal Antibody

Applications

Tested Dilution

Publications

Immunocytochemistry (ICC/IF)

0.25-2 µg/mL

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Rabbit / IgG

Class

Polyclonal

Type

Antibody

Immunogen

Recombinant Human SYNPO2. Recombinant protein control fragment (Product #RP-106243). if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:SYNPO2,uniProtId:Q9UMS6-1,ncbiNodeId:9606,antigenRange:66-151,antigenLength:1093,antigenImageFileName:PA5-65578_SYNPO2_Q9UMS6-1_Rabbit.svg,antigenImageFileNamePDP:PA5-65578_SYNPO2_Q9UMS6-1_Rabbit_PDP.jpeg,sortOrder:1}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

0.3 mg/mL

Purification

Antigen affinity chromatography

Storage buffer

PBS, pH 7.2, with 40% glycerol

Contains

0.02% sodium azide

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Wet ice

RRID

AB_2665156

Product Specific Information

Immunogen sequence: YPEVIKLMESI TDSLQMLIKR PSSGISEALI SENENKNLEH LTHGGYVEST TLQIRPATKT QCTEFFLAPV KTEVPLAENQ RSGPD

Highest antigen sequence identity to the following orthologs - mouse 65%, rat 64%.

Target Information

SYNPO2 was initially identified as myopodin, a member of the synaptopodin family that contains one PPXY motif and multiple PXXP motifs. It colocalizes with alpha-actinin and is found at the Z-disc and during stress conditions will translocate to the nucleus, suggesting that it is part of signaling pathways in addition to its function as a structural protein. SYNPO2 has been shown to bind to calmodulin, alpha-actinin, and smooth muscle myosin and will stimulate actin polymerization in a calmodulin dependent manner, consistent with its proposed role in organizing the cytoskeleton. While deletion of SYNPO2 has been reported to be highly correlated with the invasiveness of prostate cancers, other reports suggest that down-regulation of SYNPO2 reduces the invasiveness and motility of prostate cancer cells.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.